Colorectal Cancer Stem Cells and Targeted Agents

Area of Science:

• Oncology
• Stem Cell Biology
• Molecular Biology

Background:

• Cancer stem cells (CSCs) drive tumor progression, metastasis, and therapy resistance.
• Colorectal cancer (CRC) remains a significant global health challenge with high mortality.
• Colorectal cancer stem cells (CR-CSCs) are key drivers of CRC progression and recurrence.

Purpose of the Study:

• To provide a comprehensive overview of colorectal cancer stem cells (CR-CSCs).
• To summarize the origin, biomarkers, cultivation, and research techniques for CR-CSCs.
• To review signaling pathways and therapeutic strategies targeting CR-CSCs.

Main Methods:

• Literature review of CR-CSC research.
• Summary of CR-CSC identification and cultivation methods.
• Analysis of signaling pathways (Wnt, JAK/STAT3, Notch, Hh) regulating CR-CSC stemness.
• Review of current and emerging anti-CR-CSC drugs and therapies.

Main Results:

• CR-CSCs possess self-renewal and differentiation capacities, contributing to metastasis and resistance.
• Key signaling pathways like Wnt, JAK/STAT3, Notch, and Hh are critical for CR-CSC stemness.
• Various biomarkers and research techniques aid in CR-CSC identification and study.
• Emerging drugs target specific pathways and regulators to eliminate CR-CSCs.

Conclusions:

• Targeting CR-CSCs offers a promising strategy to inhibit metastasis, enhance treatment efficacy, and reduce recurrence in colorectal cancer.
• Understanding CR-CSC biology and regulatory pathways is essential for developing novel therapeutic agents.
• This review provides insights into current anti-CR-CSC agents and potential future therapies.